CPE CBRND-FY26 APBI Contract Opportunities.pdf
PDF 4 MB Posted
- Attached to
- 2026 APBI Save the Date Federal contract opportunity
- Solicitation number
- Not on record
- Issued by
- Department of the Army
About this file
This is an Advanced Planning Briefing to Industry (APBI) for FY26 Aberdeen Proving Ground contract opportunities managed by the Center for Program Engineered Expertise (CPE CBRND) under the Chemical and Biological Defense Program.
The briefing covers multiple contracting vehicles and programs across three primary initiatives: the Countering Weapons of Mass Destruction (CWMD) OTA, Medical CBRN Defense (MCDC) OTA, and Joint Project Manager (JPM) portfolios. The CWMD OTA, with a $10B ceiling through November 2027, supports rapid prototyping for technologies addressing CBRN operational environments, WMD defeat, force protection, C4ISR systems, F3EAD processes, and nuclear deterrence. The MCDC OTA, ceiling $16.7B through 2036 with 310 consortium members (70% small business), focuses on detection, prevention, and treatment of CBRN medical countermeasures. Additionally, a Broad Other Transaction Authority Announcement (CWMD BOTAA-24-01) remains open through February 2029 for prototype and follow-on production efforts. Specific FY26-FY29 programs include Wearable All-Hazard Remote Monitoring (WARP 2) at $30-35M for 2QFY27 release, Far Forward Biological Sequencing (FFBS) at $12-17M, Forward Area Mobility Spray-System Aircraft Interior Decontamination at $4-8M, and multiple medical initiatives including RAPID ($40M), CADENCC ($60M for 1QFY27), PACE ($60M), and GUIDE ($20M). JPM CBRN Medical programs include Beacon ($60-75M over 5 years, 2QFY26 release), ProTecS (OTA, 4QFY26), Host Directed Therapeutics consortium ($30M annually, 3-4 actions yearly), Prophylaxis in Advanced Development (2QFY28), and Vaccine Acceleration by Modular Progression (multiple efforts totaling $100M+). Supporting acquisition vehicles include JE-RDAP MA IDIQ ($8.27B through November 2027, 171 contractors), JE-CLaSS II ($907M through January 2031), Commercial Item IDIQ (100% small business set-aside, $500M through 2030), and Medical Countermeasures BAA (open through June 2027). The briefing emphasizes non-traditional contractor participation (88% of MCDC awards), open communications without FAR formalization, negotiable IP rights, and streamlined white paper submissions rather than formal proposals for OTA efforts.
View the file
Other files for this federal contract opportunity
Show all 23
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
FY26 ABERDEEN PROVING
GROUND ADVANCED PLANNING
BRIEFING TO INDUSTRY
Mr. Keith Batchelor Program Manager - CWMD & MCDC (OTA) CPE CBRND, Chief Contracting Office (CCO)
UNCLASSIFIED/Approved for Public Release
CPE CBRND SPONSORED CONSORTIA
• A consortium is simply an organization united through a formal agreement o Currently 700 contractors, academic institutions, and not-for-profit organizations o www.cwmdconsortium.org or www.medcbrn.org
• All share common vision, mission, and values o Innovation through collaboration o Rapidly develop and deliver prototype technologies
• Led by an Executive Committee and managed by Advanced Technology International (ATI) o Established tool set for organizing and running consortia o Experienced at finding and on-boarding new technology providers o Advanced bid management software including evaluation tools (BIDS)
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 2UNCLASSIFIED/Approved for Public Release http://www.cwmdconsortium.org/ http://www.cwmdconsortium.org/ http://www.medcbrn.org/
COUNTERING WEAPONS OF MASS DESTRUCTION (CWMD) OTHER
TRANSACTION AGREEMENT (OTA) SCOPE
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 3UNCLASSIFIED/Approved for Public Release
• Provides rapid prototyping for technologies that enable or enhance the understanding of the Chemical, Biological Radiological, and Nuclear (CBRN) operational environment, threats, and vulnerabilities; control, defeat, disable, and/or dispose of Weapons of Mass Destruction (WMD) threats; safeguard the force while responding to natural and manmade disasters; and promote the cooperation, coordination, interoperability, and decision making between agencies, all levels of government, and with partner nations.
• Technical Objective Areas o CBRN counter-proliferation, nonproliferation, and defense equipment;
o Installation and force protection;
o Command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) systems for WMD detection, localization, identification, and tracking and CBRN response operations;
o Technologies that support the find, fix, finish, exploit, analyze, and disseminate (F3EAD) process;
o Preparing for and combatting improvised threats and the improvised explosive device network;
o WMD precursor, agent, and device defeat or neutralization;
o Ensuring nuclear deterrence;
o Manned and unmanned platforms capable of supporting CWMD operations;
o Technologies that enhance the effectiveness of forces that are tasked to conduct CWMD operations;
o Other operations related to the CWMD mission.
MEDICAL CBRN DEFENSE OTA SCOPE
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 4UNCLASSIFIED/Approved for Public Release
Enabling a Whole of Government Response to WMDs
• The principal purpose of the OTA is to facilitate collaboration between Government and Industry Partners to conduct research and development (R&D) into medical, pharmaceutical, and diagnostic technologies, to develop medical countermeasures and enhance mission effectiveness of military personnel in CBRN contested environments.
• Objective Areas o Detection: Systems and devices to identify CBRN agents and assist diagnostic decisions o Prevention: Prophylaxis, pretreatment, and post-exposure prophylaxis o Treatment: Therapeutics (post-exposure, post-symptomatic)
KEY OTA FEATURES
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 5UNCLASSIFIED/Approved for Public Release
OTAs have the following key features that enhance both the contractor and Government experience:
o Open Communications: Government requiring office and Consortium Members are free to discuss any project attributes including cost, schedule and performance, new ideas/approaches, forecasts, etc.
No need to formalize discussions Formal discussions pursuant to the Federal Acquisition Regulation (FAR) and its supplements are not required Exceptions:
• Cannot discuss proprietary information of another contractor
• Discussions are closed during evaluation periods (Procurement Integrity Act does apply) o “Commercial Like” financing and payment terms o Follow-on Production (successful completion or unanticipated favorable results) o Negotiable IP and data rights (Bayh-Dole Act does not apply) o Flexible - (Terms & Conditions, agreement types, evaluation process, success metrics, deliverables) o Streamlined – (Enhanced White Paper w/ROM vice formal proposal).
o FAR DOES NOT APPLY
TYPICAL SCHEDULE FOR ENHANCED WHITE PAPER
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 6UNCLASSIFIED/Approved for Public Release
Milestone
* Estimated Completion
Timeline (Business Days)
CWMD / MCDC
Issue Request For Prototype Proposal: Internal Reviews, Release Draft RPP, Release Final RPP 11 11
Proposal Submission: Write Enhanced White Papers/Submission, Compliance Reviews 31 31
Source Selection: Technical Evaluations, Generate Competitive Evaluation Report 31 31
Negotiations/Award Documentation Package: Finalize SOW, Complete Award Documentation, Issue Proposal Update Letter 22 22
Project Award: Updated Proposal Submission, Cost Analysis, Technical Direction Letter, Determination and Findings, Price Reasonableness Determination, Execute
Project Agreement
54 54
* Estimated Completion Timelines are not to be construed as policy. Each OT requirement and situation will be determined on a case-by-case basis.
KEY PROGRAM ROLES & RESPONSIBILITIES
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 7UNCLASSIFIED/Approved for Public Release
Program Management Office (JPEO-CBRND) •Execute program strategy and marketing •Manage operations
•Monitor Cost, Schedule, and Technical Performance •Provide acquisition support and expertise
•Contractual (1101/2 series) •Technical (0800 and 1300 series)
•Maximize customer service and support •Training by Subject Matter Experts to customers
Agreements Officer (ACC-NJ) •Review and approve requirements •Review and approve evaluations of white papers/proposals
•Conduct Cost/Price Analysis •Prepare Determination and Findings -- approving that proposal requirements are met
•Facilitation of legal and SCO reviews •Perform post-award administration
Consortium Management Firm (ATI) •Manage consortium
•Maintain on-line process for bid management •Complete compliance checks •Award sub-agreements •Member Training & Mentoring
•Monitor post-award performance against technical milestones
•Manage payment process •Manage reporting and deliverables
Agreements Officer’s Representative •Write requirements with program team •Conduct evaluations •Draft selection memoranda •Monitor cost, schedule, and technical performance
•Approve deliverables •Approve payments, etc.
•Communicate any changes to PMO/AO
• FY 16, 17 RPP (5 Projects), 5 Awards, 0 Basket; FY 16-17 Basket Pulls – 1
• FY 18 RPP (11 Projects), 6 Awards, 0 Basket; FY 18 Basket Pulls – 10
• FY 19 RPP (12 Projects), 21 Awards, 0 Basket, FY 19 Basket Pull – 4
• FY 20 RPP (17 projects), 27 Awards, 0 Basket, FY 20 Basket Pull – 1
• FY 21 RPP (6 Projects), 18 Awards, 13 Basket, FY 21 Basket Pull – 0
• FY 22 RPP (15 Projects), 7 Awards, 26 Basket; FY 22 Basket Pulls – 2
• FY 23 RPP (1 Projects), 9 Awards, 3 Basket; FY23 Basket Pulls – 1
• FY 24 RPP (4 Projects), 4 Awards, 4 Basket; FY24 Basket Pulls – 1
• FY 25 RPP (3 Projects), 0 Awards, 0 Basket; FY25 Basket Pulls – 0
Traditional, 12%
Non-Traditional, 88%
Non-Traditional/Traditional Distribution
Academic, 9%
Large, 13%
Not-For- Profit, 7%
Small, 70%
310 Members 107 Total Awarded Projects 68 Active Funded Projects
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 8UNCLASSIFIED/Approved for Public Release
• Awarded Ceiling - $ 8,810,534,471
• Total Cost (w/CMF Fee) $ 8,952,409,186
• Funded To Date - $7,883,318,283
• Disbursed to date $7,936,993,023
• Paid to Performer - $4,478,022,117
Traditional, 16%
Non-Traditional, 84%
Non-Traditional/Traditional Distribution
Academic, 5%
Large, 18%
Not-For- Profit, 4%Small, 73%
• FY 18 RPP (34 Projects), 22 Awards, 00 Basket; FY 18 Basket Pull - 1
• FY 19 RPP (37 Projects), 51 Awards, 00 Basket, FY 19 Basket Pull - 5
• FY 20 RPP (42 projects), 30 Awards, 07 Basket, FY 20 Basket Pull - 4
• FY 21 RPP (19 Projects), 52 Awards, 45 Basket, FY 21 Basket Pull - 7
• FY 22 RPP (08 Projects), 24 Awards, 28 Basket, FY 22 Basket Pull - 10
• FY 23 RPP (18 Projects), 14 Awards, 63 Basket, FY 23 Basket Pull - 10
• FY 24 RPP (05 Projects), 00 Awards. 00 Basket, FY 23 Basket Pull – 0
• FY 25 RPP (01 Projects), 01 Awards, 01 Basket, FY 25 Basket Pull - 0
403 Members 204 Total Awarded Projects 76 Active Funded Projects
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 9UNCLASSIFIED/Approved for Public Release
• Awarded Ceiling - $1,642,214,491
• Total Cost (w/CMF Fee) $1,672,983,021
• Funded To Date - $1,155,127,528
• Disbursed (Inc CMF C&F) $ 1,167,009,237
• Paid to Performer - $1,137,966,034
BROAD OTHER TRANSACTION AUTHORITY ANNOUNCEMENTS
(BOTAA)
Combating Weapons of Mass Destruction (CWMD)
• CWMD BOTAA-24-01; W911SR-24-R-CWMD Published 2/7/2024 (SAM.gov)
Mission Areas:
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 10UNCLASSIFIED/Approved for Public Release
• CBRNE counter-proliferation, nonproliferation, and defense equipment.
• Installation and force protection.
• Command, Control, Communications, Computers, Intelligence, Surveillance, and Reconnaissance (C4ISR) systems for WMD detection, localization, identification, and tracking and CBRNE response operations.
• Technologies that support the Find, Fix, Finish, Exploit, Analyze, and Disseminate (F3EAD) process.
• Preparing for and combatting improvised threats and the improvised explosive device network.
• WMD precursor, agent, and device defeat or neutralization.
• Ensuring nuclear deterrence.
• Manned and unmanned platforms capable of supporting CWMD operations.
• Technologies that enhance the effectiveness of forces that are tasked to conduct CWMD operations.
• Software and Artificial Intelligence (AI) platform technology to achieve
CBRN Defense integration, interoperability, and interdependence across all warfighting domains and functions.
• Other operations related to the CWMD mission
Modernization Focus Areas:
• Flexible, Scalable, and Interoperable Threat Agnostic Detection
• Threat Characterization and Hazard Modeling
• Artificial Intelligence and Machine Learning
• Wearable Sensors
• CBRN Information Nested with Joint All-Domain Command and
Control
• Unobtrusive Individual Protection
• Biothreat Containment and Aeromedical Evacuation to Assure
Continuity of Operations
• Quick and Effective Decontamination to Contain and Neutralize
Spread
CONTACT @CPECBRND
Mr. Keith Batchelor OTA Program Manager CPE CBRND, Contract Management Office roger.k.batchelor2.civ@army.mil
Mr. Lee Hess Senior Contract Integrator (MCDC) CPE CBRND, Contract Management Office lee.a.hess.civ@army.mil https://www.linkedin.com/company/jpeocbrnd/ https://www.facebook.com/JPEOCBRND https://www.youtube.com/c/jpeocbrnd https://twitter.com/JPEOCBRND/ mailto:roger.k.batchelor2.civ@army.mil mailto:lee.a.hess.civ@army.mil
Ms. Deborah Olson Joint Project Manager for Chemical, Biological, Radiological and Nuclear Special Operations Forces (JPM CBRN SOF)
FY26 ABERDEEN PROVING
GROUND ADVANCED PLANNING
BRIEF TO INDUSTRY
FY26 APBI
UPDATE SINCE FY25 APBI
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI
UNCLASSIFIED/Approved for Public Release
• TOTAL ACTIONS BRIEFED: 2
o Wearable All-Hazard Remote Monitoring (WARP) Production o All-Purpose Personal Protective Ensemble Modernization (AP-PPE MOD) Theater
• RFPs RELEASED: 2
• ACTIONS AWARDED: 2
WEARABLE ALL HAZARD REMOTE MONITORING PROGRAM –
INCREMENT 2 (WARP 2)
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI
UNCLASSIFIED/Approved for Public Release
DESCRIPTION: WARP Increment 2 (WARP 2) is a systems of wearable sensors or monitors that will be worn on the body and algorithms to actively monitor an individual warfighter’s physiological status on the objective in near real time to identify potential early exposure to Chemical Warfare Agents (CWAs) to include non-traditional agents (NTAs) and Pharmaceutical Based Agents (PBAs).
CONTRACT TYPE and CONTRACT VEHICLE: TBD, Other Transaction via BOTAA-24-01
ESTIMATED VALUE: $30M-$35M
CONTRACTING CONTACT: TBD; Technical POC: Traci Sheely, (443) 910-5289, traci.l.sheely.civ@army.mil
DRAFT SOLICITATION RELEASE: N/A
SOLICITATION #: Via BOTAA-24-01
ESTIMATED SOLICITATION RELEASE DATE: 2QFY27
PRIOR/CURRENT CONTRACT INFORMATION:
Contract Number: N/A Incumbent Contractor: N/A mailto:traci.l.sheely.civ@army.mil
FAR FORWARD BIOLOGICAL SEQUENCING (FFBS) – INCREMENT 3
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI
UNCLASSIFIED/Approved for Public Release
DESCRIPTION: The FFBS system will provide rapid handheld biological sequencing to identify an unlimited number of bio-warfare agents (BWA) to include emerging or engineered biological weapon threats.
CONTRACT TYPE and CONTRACT VEHICLE: TBD, Other Transaction via BOTAA-24-01
ESTIMATED VALUE: $12M-$17M
CONTRACTING CONTACT: TBD; Technical POC: Traci Sheely, (443) 910-5289, traci.l.sheely.civ@army.mil
DRAFT SOLICITATION RELEASE: N/A
SOLICITATION #: Via BOTAA-24-01
ESTIMATED SOLICITATION RELEASE DATE: 2QFY27
PRIOR/CURRENT CONTRACT INFORMATION:
Contract Number: N/A
FORWARD AREA MOBILITY SPRAY-SYSTEM (FAMS-S)
AIRCRAFT INTERIOR DECONTAMINATION (AID)
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI
UNCLASSIFIED/Approved for Public Release
DESCRIPTION: FAMS-S is a “system of systems” that allows the Special Operations Forces to decontaminate surfaces from chemical and biological exposure. Current systems only decontaminate the exterior of vehicles, vessels and aircraft;
however, the FAMS-S AID will be required to decontaminate the interior components including sensitive instrumentation.
CONTRACT TYPE and CONTRACT VEHICLE: TBD, Other Transaction via BOTAA-24-01
ESTIMATED VALUE: $4M-$8M
CONTRACTING CONTACT: TBD; Technical POC: Traci Sheely, (443) 910-5289, traci.l.sheely.civ@army.mil
DRAFT SOLICITATION RELEASE: N/A
SOLICITATION #: Via BOTAA-24-01
ESTIMATED SOLICITATION RELEASE DATE: 2QFY27
PRIOR/CURRENT CONTRACT INFORMATION:
Contract Number: N/A
FY26 ABERDEEN PROVING
GROUND ADVANCED PLANNING
BRIEFING TO INDUSTRY
UNCLASSIFIED/Approved for Public Release
Bruce Goodwin Joint Project Lead CBRND Enabling Biotechnologies (JPL EB)
DATA & TECHNOLOGY
INTEGRATION FOR READINESS
(DTIR) JPL EB
3FY26 APBI
RAPID ACCESS TO PRODUCTS IN DEVELOPMENT (RAPID)
DESCRIPTION: RAPID Storage & Stability is for the retrieval/transition, storage, stability, distribution, receipt, and disposal of government owned biological and pharmaceutical-related chem-bio defense material, such as vaccines and biologics that are subject to US Food and Drug Administration (FDA) regulations, and other related federal agencies.
CONTRACT TYPE and CONTRACT VEHICLE: OTA
ESTIMATED VALUE: $40M
CONTRACTING CONTACT: ACC APG
DRAFT SOLICITATION RELEASE: RFI 1Q FY26
SOLICITATION #: TBD
ESTIMATED SOLICITATION RELEASE DATE: RFP 2Q FY26
PRIOR/CURRENT CONTRACT INFORMATION:
Contract Number: NA Incumbent Contractor: NA
“The forecast data is for planning purposes, does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal, and is not a commitment by the government to purchase the desired products and services."
UNCLASSIFIED//Approved for Public Release
CBRN ADVANCE DEFENSE ENABLING NETWORK AND CLINICAL
CAPABILITY (CADENCC)
“The forecast data is for planning purposes, does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal, and is not a commitment by the government to purchase the desired products and services."
UNCLASSIFIED//Approved for Public Release
FY26 APBI 20
DESCRIPTION: The CBRN Advance Defense Enabling Network and Clinical Capability (CADENCC) delivers a clinical trial network leveraging existing pre-positioned clinical sites and assets, regulatory-approved disease-agnostic master protocols, varied site types and wider geographic coverage, and decentralized data collection using digital health technologies that accelerates clinical evaluation of medical countermeasures (MCM).
CONTRACT TYPE and CONTRACT VEHICLE: OTA
ESTIMATED VALUE: $60M
CONTRACTING CONTACT: ACC APG
DRAFT SOLICITATION RELEASE: RFI 2Q FY26
SOLICITATION #: TBD
ESTIMATED SOLICITATION RELEASE DATE: RFP 1Q FY27
PRIOR/CURRENT CONTRACT INFORMATION:
Contract Number: NA Incumbent Contractor: NA
PROACTIVE ADVANCED COUNTERMEASURE EVALUATION (PACE)
“The forecast data is for planning purposes, does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal, and is not a commitment by the government to purchase the desired products and services."
UNCLASSIFIED//Approved for Public Release
FY26 APBI 21
DESCRIPTION: PACE will transition computationally optimized medical countermeasure (MCMs) against novel or modified viral, toxin or chemical threat agents up to a Pre-Clinical Development Phase (achieving a RAPID Tier 1 milestone) by leveraging purpose-built laboratory systems, computational tools, and high throughput technologies.
CONTRACT TYPE and CONTRACT VEHICLE: OTA
ESTIMATED VALUE: $60M
CONTRACTING CONTACT: ACC APG
DRAFT SOLICITATION RELEASE: RFI 2Q FY27
SOLICITATION #: TBD
ESTIMATED SOLICITATION RELEASE DATE: RFP 1Q FY28
PRIOR/CURRENT CONTRACT INFORMATION:
GENERATIVE UNCONSTRAINED INTELLIGENT DRUG
ENGINEERING (GUIDE)
“The forecast data is for planning purposes, does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal, and is not a commitment by the government to purchase the desired products and services."
UNCLASSIFIED//Approved for Public Release
FY26 APBI 6
DESCRIPTION: GUIDE’s purpose-built supply of protein-protein interaction data for the purpose of training and optimizing AI/ML models in support of the integrated computational platform to accelerate medical countermeasure (MCM) development against novel or modified viral, toxin or chemical threat agents.
CONTRACT TYPE and CONTRACT VEHICLE: OTA
ESTIMATED VALUE: $20M
CONTRACTING CONTACT: ACC APG
DRAFT SOLICITATION RELEASE: RFI 2Q FY28
SOLICITATION #: TBD
ESTIMATED SOLICITATION RELEASE DATE: RFP 1Q FY29
PRIOR/CURRENT CONTRACT INFORMATION:
ADVANCING TECHNOLOGY
PLATFORMS (ATP)
JPL EB
NEW MODALITIES FOR PROPHYLACTIC MEDICAL
COUNTERMEASURES
“The forecast data is for planning purposes, does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal, and is not a commitment by the government to purchase the desired products and services."
UNCLASSIFIED//Approved for Public Release
FY26 APBI 24
DESCRIPTION: Contracting action to investigate and develop new methods for delivering prophylactic countermeasures.
Effort will focus on pre-exposure, with emphasis on broad spectrum coverage. Multiple contracts may be considered.
CONTRACT TYPE and CONTRACT VEHICLE: TBD, likely OTA (MCDC)
ESTIMATED VALUE: $30-50, multi-year effort
CONTRACTING CONTACT: ACC-NJ, TBD
DRAFT SOLICITATION RELEASE: 1QFY29
SOLICITATION #: TBD
ESTIMATED SOLICITATION RELEASE DATE: TBD
PRIOR/CURRENT CONTRACT INFORMATION: N/A
Contract Number:
Incumbent Contractor:
MEDICAL COUNTERMEASURE MANUFACTURING OPTIMIZATION
“The forecast data is for planning purposes, does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal, and is not a commitment by the government to purchase the desired products and services."
UNCLASSIFIED//Approved for Public Release
FY26 APBI 25
DESCRIPTION: Contracting action to secure priority access for emergency response and optimize manufacturing processes for prophylactic, or therapeutic products in development. Multiple awards possible. Effort will prioritize chemical prophylaxis viable manufacturing processes.
CONTRACT TYPE and CONTRACT VEHICLE: TBD, likely OTA (MCDC)
ESTIMATED VALUE: $10-20M, multi-year effort
CONTRACTING CONTACT: ACC-NJ, TBD
DRAFT SOLICITATION RELEASE: 1QFY27
SOLICITATION #: TBD
ESTIMATED SOLICITATION RELEASE DATE: TBD
PRIOR/CURRENT CONTRACT INFORMATION: N/A
NON-HUMAN PRIMATE (NHP) PRIORITY ACCESS
“The forecast data is for planning purposes, does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal, and is not a commitment by the government to purchase the desired products and services."
UNCLASSIFIED//Approved for Public Release
FY26 APBI 26
DESCRIPTION: Contracting action to secure priority access to NHP supply for time of need, to support CBDP enterprise medical countermeasure research and medical rapid response needs
CONTRACT TYPE and CONTRACT VEHICLE: TBD, likely IDIQ
ESTIMATED VALUE: $10-20M, multi-year effort
CONTRACTING CONTACT: ACC-APG, TBD
DRAFT SOLICITATION RELEASE: 3-4QFY26
SOLICITATION #: TBD
ESTIMATED SOLICITATION RELEASE DATE: TBD
PRIOR/CURRENT CONTRACT INFORMATION: N/A
NEW ALTERNATIVE METHODS FOR THE EVALUATION OF
MEDICAL COUNTERMEASURES
a commitment by the government to purchase the desired products and services."
FY26 APBI 11UNCLASSIFIED//Approved for Public Release
DESCRIPTION: New Alternative Methods (NAMs) and approaches to evaluate medical countermeasures. Looking for opportunity to accelerate, and de-risk medical countermeasure development through implementation of alternative approaches (organoids, AI/ML, etc). Opportunity could include multiple awards.
CONTRACT TYPE and CONTRACT VEHICLE: TBD, likely OTA (MCDC)
ESTIMATED VALUE: $20-30M, multi-year effort
CONTRACTING CONTACT: ACC-NJ, TBD
DRAFT SOLICITATION RELEASE: 3-4QFY26
SOLICITATION #: TBD
ESTIMATED SOLICITATION RELEASE DATE: TBD
PRIOR/CURRENT CONTRACT INFORMATION: N/A
Contract Number:
“The forecast data is for planning purposes, does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal, and is not
Mr. Bruce Goodwin Joint Product Lead CBRND Enabling Biotechnologies bruce.g.goodwin4.civ@army.mil
Ms. Nicole Dorsey Deputy Joint Product Lead CBRND Enabling Biotechnologies nicole.m.dorsey3.civ@army.mil https://www.linkedin.com/company/jpeocbrnd/ https://www.facebook.com/JPEOCBRND https://www.youtube.com/c/jpeocbrnd https://twitter.com/JPEOCBRND/ mailto:bruce.g.goodwin4.civ@army.mil mailto:nicole.m.dorsey3.civ@army.mil
Date
Ms. Jennifer Buchness Lead Procurement Coordinator CPE CBRND, Chief Contracting Office (CCO)
UNCLASSIFIED/Approved for Public Release
FY26 ABERDEEN PROVING
BRIEFING TO INDUSTRY
OVERVIEW OF PARTNERING VEHICLES
Awards outside of MA IDIQs and OTAs
• FAR-based awards of legacy components
• Small Business Innovative Research (SBIRs)
OASIS+
JE-CLaSS
II
JE-RDAP
MCS BAAARMY OPEN
SOLUTIONS
(AOS)
CWMD
BOTAA
CWMD
OTA
MCDC
OTA
Stand- Alone
Contracts
Press Releases
Training Workshops
Office Calls
Web Publications
OTA
GMM
ATI
Consortium
APBI
NDIA
CBRNE
Conference
MCDC & CWMD OTAs:
• Inspires technical innovation and expedited awards
• Expands industrial base to “Non-Traditional” Defense contractors
• MCDC PoP through 2036
• $16.7B ceiling
• CWMD through Nov 2027
• $10B ceiling
CWMD BOTAA
• Broad Other Transaction Authority
Announcement (BOTAA) for prototype and follow-on production projects
• Announcement open through Feb 2029
Army Open Solutions (AOS)
• Multiple solicitation authorities to include Commercial
Solutions Openings (CSOs), Broad Agency Announcement
Professional Support Services through OASIS+
• Professional Support across 6 business areas
• Task Order PoPs vary (base + options
Logistics and sustainment MA IDIQ
• Contractor Logistics Support (CLS) & performance-based logistics, training, sustainment, acquisition logistics
• PoP through Dec 2030; $907M ceiling
Research, Development, & Production MA
IDIQ
• Research, development, production, procurement, fielding, and initial sustainment
• PoP through Nov 2027; $8.27B ceiling
Commercial Item IDIQ
• CBRN defense commercial items, equipment, and ancillary training
• PoP through 2030, $500M ceiling
Medical Countermeasures BAA
• Flexible Broad Agency Announcement (BAA) leading to contracts, grants, cooperative agreements, OTAs, and TIAs
• Announcement open through Jun 2027
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or
COMMERCIAL
ITEM IDIQ
request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 2
PROFESSIONAL SUPPORT SERVICES (OASIS+)
request for proposal and is not a commitment by the government to purchase products or services.”
UNCLASSIFIED/Approved for Public ReleaseFY26 APBI 3
• Non-personal, professional support services on behalf of requirements owners (Joint Project Manager (JPMs); Joint Project Lead (JPLs); HQ; Joint Agency Partners) o Business areas: Acquisition, Logistics, Business, Scientific, Engineering & Technical, and Research and Development o Organizations supported: JPEO-CBRND HQ, JPM/Ls, USAF CBRN Branch, National Guard Bureau, Naval Surface Warfare Center, USMC
• Primary Contract Vehicle (OASIS+):
o Successor contract vehicle to JE-OPETS (exp. Aug 2025) o ACC-executed/administered Task Orders (TOs) against GSA’s One Acquisition Solution for
Integrated Services Plus (OASIS+) IDIQ Task Order Period of Performance: 2025 - 2030
• 1-year Base and four 1-year Options
• Other Alternatives o Army CHESS for IT-related services Other vehicles may be considered for cloud services, software development, and continuous software evolution service-type contracts o Requirements owners may use other approaches (standalone; support agreements)
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or
JE-CLASS II
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
UNCLASSIFIED/Approved for Public Release
FY26 APBI 32
• Joint Enterprise – Contracted Logistics and Services Support (JE-CLaSS) II available to CBRND Enterprise
• MA IDIQ
o Successor contract vehicle to JE-CLaSS o 4-year Base (through Jan 2027) with one 4-year Options (through Jan 2031) o $907M ceiling o Orders may have up to a 5-year Period of Performance (PoP)
• Domain 1: 23 contract holders o System Maintenance and Reset, Field Maintenance Support, Supply Chain Management (Stocking and
Reporting, Logistics and Warehousing, Calibration), Training, Transport of Equipment and Materials, Provisioning, and Product Support Analysis o Orders competed as fair opportunity; Small Business Set-Aside (SBSA) determined by “Rule-of-2”
• Domain 2: 18 contract holders o Acquisition logistics services and Product supportability/sustainability support, Training planning and support, Program Management, Property Accountability, and Quality Assurance o 100% SBSA
• List of contract holders are posted at https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/
JE-RDAP
• Joint Enterprise – Research, Development, Acquisition and Production/Procurement (JE-
RDAP)
• Multiple Award Indefinite Delivery Indefinite Quantity (MA IDIQ) o 10-year ordering period (through Nov 2027) o $8.27B ceiling o Orders may extend up to 5 years beyond expiration of ordering period
• Scope: Research, development, acquisition, production, procurement, fielding and initial sustainment of CBRND systems, equipment, medical devices, information systems, and materiel o Orders competed as fair opportunity amongst 171 contract holders Small business considerations available o List of contract holders are posted at https://www.jpeocbrnd.osd.mil/Work-With-Us/ Contract holders may team with other contract holders or bring on external partners/subcontractors to provide future/new technologies and capabilities
• Available to the CBRND Enterprise
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
UNCLASSIFIED/Approved for Public Release
FY26 APBI 33
https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/ https://www.jpeocbrnd.osd.mil/Work-With-Us/
CBRN COMMERCIAL ITEM IDIQ
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
UNCLASSIFIED/Approved for Public Release
FY26 APBI 34
• MA IDIQ administered by the GSA Assisted Acquisition Services, Army (AAS, Army) o 100% Small Business Set-Aside (SBSA) o $500M ceiling o 5-year PoP (2025 – 2030)
1-year Base and four 1-year Options
• Scope: procurement commercial items, equipment, and Ancillary Training in support of the Joint Forces and CBRND Enterprise
• Concept: Speed and flexibility for the procurement of commercial items and equipment, through a streamlined process o Supplements JE-RDAP and JE-CLaSS II o Available to CBRND Enterprise
• Target speed: Under 30 days from GSA acceptance of requirements package to award
ARMY OPEN SOLICITATION (AOS)
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
UNCLASSIFIED/Approved for Public Release
FY26 APBI 35
• Purpose: Enable Army to rapidly acquire and deliver innovative solutions to the Warfighter using commercial technology advancements and research and development solutions
• Multiple solicitation authorities to include Commercial Solutions Openings (CSOs) and Broad Agency Announcements (BAAs) o FAR and non-FAR based awards o Open Indefinitely (sam.gov) o Government can submit Active Capability Gaps
(ACGs) and Calls for Solutions and Industry can submit (unsolicited) solution briefs
• Use when:
o Government is seeking unique, creative, or innovative industry solutions Not appropriate when requirement is mature, and an innovative solution is not required
• Example areas:
o Intelligence, Electronic Warfare and Sensors o Army Enterprise Business Solutions o Tactical Communications o Soldier Equipment o Simulation Training and Instrumentation o Ground Combat Systems o Missiles and Space o Aviation o Supply Chain and Logistics o Installation Support and Innovation o Advanced Manufacturing
MEDICAL COUNTERMEASURES BAA
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 36
UNCLASSIFIED/Approved for Public Release
• Medical Countermeasures Broad Agency Announcement (BAA)
• Can issue FAR-based contracts, grants, cooperative agreements, OTAs, and Technology Investment Agreements (TIAs) in support of novel solutions and improved methods to develop medical countermeasures o Announcement open through Jun 2027 o Government may issue Calls for Proposals or Offerors may submit unsolicited proposals against Mission areas.
• Announcement located on sam.gov (https://sam.gov/opp/f2d01f5a6c444e32af543e9519a0805f/view ) and Grants.gov
• Mission areas:
o Medical Biological Prophylaxis o Medical Chemical and Biological Countermeasures o Medical Radiological Countermeasures o Medical Diagnostic and Surveillance Systems o Enabling Biotechnologies and Response Systems https://sam.gov/opp/f2d01f5a6c444e32af543e9519a0805f/view
CWMD BOTAA
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 37
UNCLASSIFIED/Approved for Public Release
• Chemical Weapons of Mass Destruction Broad Other Transaction Authority Announcement (CWMD
BOTAA)
• Prototype and follow-on production efforts directed toward development of enabling technologies that speed up the advanced development process o Announcement open through Feb 2029 o Government may issue Requests for Project
Proposals (RPPs) or Offerors may submit unsolicited proposals against Mission areas.
• Announcement located on sam.gov (https://sam.gov/opp/2d04622b25364669857a6a61c5 76ade9/view )
• Mission areas:
o CBRNE counter-proliferation, nonproliferation, and defense equipment.
o Installation and force protection.
o Command, Control, Communications, Computers, Intelligence, Surveillance, and Reconnaissance (C4ISR) systems for WMD detection, localization, identification, and tracking and CBRNE response operations.
o Technologies that support the Find, Fix, Finish, Exploit, Analyze, and Disseminate (F3EAD) process.
o Preparing for and combatting improvised threats and the improvised explosive device network.
o WMD precursor, agent, and device defeat or neutralization.
o Ensuring nuclear deterrence.
o Manned and unmanned platforms capable of supporting CWMD operations.
o Technologies that enhance the effectiveness of forces that are tasked to conduct CWMD operations.
o Software and Artificial Intelligence (AI) platform technology to achieve CBRN Defense integration, interoperability, and interdependence across all warfighting domains and functions.
o Other operations related to the CWMD mission.
https://sam.gov/opp/2d04622b25364669857a6a61c576ade9/view https://sam.gov/opp/2d04622b25364669857a6a61c576ade9/view
DOING FAR-BASED BUSINESS WITH THE GOVERNMENT
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 38
UNCLASSIFIED/Approved for Public Release
• Joint Enterprise Technology Tool (JETT)
• SAM.gov o Industry Days o Request for Information (RFIs) o Contracting Opportunities
• For Small Businesses:
o Cognizant SBA representative o Army Office of Small Business Programs o https://www.army.mil/osbp
• CPE CBRND Work With Us https://www.jpeocbrnd.osd.mil/Work-With-Us/JETT-Joint-Enterprise-Technology-Tool/)/ https://www.jpeocbrnd.osd.mil/Work-With-Us/JETT-Joint-Enterprise-Technology-Tool/)/ https://www.jpeocbrnd.osd.mil/Work-With-Us/JETT-Joint-Enterprise-Technology-Tool/)/ https://www.jpeocbrnd.osd.mil/Work-With-Us/JETT-Joint-Enterprise-Technology-Tool/)/ https://www.jpeocbrnd.osd.mil/Work-With-Us/JETT-Joint-Enterprise-Technology-Tool/)/ https://www.jpeocbrnd.osd.mil/Work-With-Us/JETT-Joint-Enterprise-Technology-Tool/)/ https://sam.gov/ https://sam.gov/ https://www.army.mil/osbp https://www.army.mil/osbp https://www.jpeocbrnd.osd.mil/Work-With-Us/)/ https://www.jpeocbrnd.osd.mil/Work-With-Us/)/ https://www.jpeocbrnd.osd.mil/Work-With-Us/)/ https://www.jpeocbrnd.osd.mil/Work-With-Us/)/ https://www.jpeocbrnd.osd.mil/Work-With-Us/)/ https://www.jpeocbrnd.osd.mil/Work-With-Us/)/
Ms. Jenny Buchness Lead Procurement Coordinator
CPE CBRND
667-201-3447 jennifer.m.buchness.civ@army.mil https://www.linkedin.com/company/jpeocbrnd/ https://www.facebook.com/JPEOCBRND https://www.youtube.com/c/jpeocbrnd https://twitter.com/JPEOCBRND/ mailto:darryl.j.colvin.civ@army.mil
CLASSIFICATION MARKING
COL John Nuckols Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical)
Jeff Zerhusen Deputy, JPM CBRN Medical
FY26 ABERDEEN PROVING
GROUND ADVANCED PLANNING
UPDATE SINCE FY25 APBI
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
UNCLASSIFIED/Approved for Public Release
APBI FY26
• TOTAL ACTIONS BRIEFED: XX
• RFPs RELEASED: XX
• ACTIONS AWARDED:
• W911SR-25-9-0001 - Other Transaction Authority For Prototype Agreement
• Initial Award – March 2025
• Modification Award – September 2025
• W911QY21R0004 – FAR IDIQ production contract for MPDS
• Initial Award – Jan 2021
• Modification Award extending contract duration to Nov 2030 – Jan 2026
BEACON
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
UNCLASSIFIED/Approved for Public Release
APBI FY26
• DESCRIPTION: The Beacon program is aimed at rapidly identifying and screening multiple chemical medical countermeasure candidates; Beacon is seeking a program integrator to manage the acquisition and testing of Government-identified candidates
• CONTRACT TYPE and CONTRACT VEHICLE: TBD
• ESTIMATED VALUE: $60-$75M over 5 years
• CONTRACTING CONTACT:
Contracting POC - ACC-APG, TBD Technical POC - JPM CBRN Medical, Amy Sands, 520-706-0082, amy.l.sands4.civ@army.mil
• ESTIMATED SOLICITATION RELEASE DATE: 2QFY26
• SOLICITATION #: TBD
• PRIOR/CURRENT CONTRACT INFORMATION: N/A
mailto:amy.l.sands4.civ@army.mil
PROTECS
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
UNCLASSIFIED/Approved for Public Release
APBI FY26
• DESCRIPTION: Prophylactic Technology Systems (ProTecS) will deliver an United States Food and Drug Administration (FDA)-approved prophylactic against a broad spectrum of nerve agents, leveraging candidate(s) identified by the Beacon program
• CONTRACT TYPE and CONTRACT VEHICLE: Other Transaction Agreement (OTA)
• ESTIMATED VALUE: TBD
• CONTRACTING CONTACT:
Contracting POC - ACC-APG, TBD Technical POC - JPM CBRN Medical, Amy Sands, 520-706-0082, amy.l.sands4.civ@army.mil
• ESTIMATED SOLICITATION RELEASE: 4QFY26
• SOLICITATION #: TBD
• PRIOR/CURRENT CONTRACT INFORMATION: N/A
mailto:amy.l.sands4.civ@army.mil
HOST DIRECTED THERAPEUTICS (HD TX)
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
UNCLASSIFIED/Approved for Public Release
APBI FY26
DESCRIPTION: The Host Directed Therapeutics (HD TX) program will be a capability-based portfolio representing a next-generation CBRN resilience initiative aimed at delivering threat agnostic host-directed medical countermeasures that enhance the body’s ability to withstand, mitigate, and recover from the complex and overlapping physiological impacts of CBRN threats. A Participant Based Agreement (PBA) is planned for a HD TX consortium with Other Transaction Agreements (OTAs), Request for Proposal (RFP), and Request For Information (RFI) releases.
CONTRACT TYPE and CONTRACT VEHICLE: Participant Basic Agreement (PBA) with OTA, RFP, and RFI releases
ESTIMATED VALUE: $30M per year, 3-4 actions per year
CONTRACTING CONTACT:
Contracting POC - ACC-APG, Brian Mazen, 520-671-3728, brian.e.mazen.civ@army.mil Technical POC - JPM CBRN Medical, Lauren Trippe, 520-672-7588, lauren.m.trippe.civ@army.mil
DRAFT SOLICITATION RELEASE: PBA RFI in 3QFY26 with PBA formation by 4QFY26; Draft RFI 4QFY26
SOLICITATION #: TBD
ESTIMATED SOLICITATION RELEASE DATE: 1QFY27
PRIOR/CURRENT CONTRACT INFORMATION: N/A
mailto:brian.e.mazen.civ@army.mil mailto:lauren.m.trippe.civ@army.mil
PROPHYLAXIS IN ADVANCED DEVELOPMENT (PAD)
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
UNCLASSIFIED/Approved for Public Release
APBI FY26
DESCRIPTION: Prophylaxis in Advanced Development (PAD) is a portfolio program to provide a prophylaxis capability that can be positioned far-forward to unburden the Force and maintain combat lethality. PAD will continue the advanced development for one prophylaxis medical countermeasure through Good Manufacturing Practices (GMP) manufacturing, phase 3 clinical trials and FDA licensure.
CONTRACT TYPE and CONTRACT VEHICLE: OTA
ESTIMATED VALUE: TBD
CONTRACTING CONTACT:
Contracting POC - ACC-APG, TBD Technical POC - JPM CBRN Medical, Nicole Lackemeyer, 520-708-0167, Nicole.l.Lackemeyer.civ@army.mil
DRAFT SOLICITATION RELEASE: 1QFY28
SOLICITATION #: TBD
ESTIMATED SOLICITATION RELEASE DATE: 2QFY28
PRIOR/CURRENT CONTRACT INFORMATION: N/A
mailto:Nicole.l.Lackemeyer.civ@army.mil
VACCINE ACCELERATION BY MODULAR PROGRESSION
(VAMP)
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
UNCLASSIFIED/Approved for Public Release
APBI FY26
• DESCRIPTION: Expediting VAMP-ENBD program’s development of vaccine platform prototype candidates through Phase I or Phase II clinical trials during an approximately staggered three-year cycle
• CONTRACT TYPE and CONTRACT VEHICLE: TBD, likely FFP or CPFF OTA Agreement through CBRND BAA
• ESTIMATED VALUE: Multiple new efforts (Phase I and II clinical trials) between FY28-32 for total of $100M+
• CONTRACTING CONTACT:
Contracting POC – Anticipate ACC-APG, Brian Mazen, 443-356-3662, brian.e.mazen.civ@army.mil Technical POC – JPM CBRN Medical, Emily Cisney, 240-457-2725, emily.d.cisney.civ@army.mil
• DRAFT SOLICITATION RELEASE: TBD
• SOLICITATION #: TBD
• ESTIMATED SOLICITATION RELEASE DATE: Request for Project Proposals (RPP) anticipated 1QFY27
• PRIOR/CURRENT CONTRACT INFORMATION: N/A
mailto:brian.e.mazen.civ@army.mil mailto:emily.d.cisney.civ@army.mil
CONTACT
COL John Nuckols Joint Project Manager Chemical, Biological, Radiological, Nuclear Defense
301-619-7400 john.t.nuckols.mil@army.mil
@CPECBRND
Updated as of 1 December 2025 | Subject to Change 8 https://www.linkedin.com/company/jpeocbrnd/ https://www.facebook.com/JPEOCBRND https://www.youtube.com/c/jpeocbrnd https://twitter.com/JPEOCBRND/ mailto:John.t.nuckols.mil@army.mil
Mr. Paul Gietka Joint Project Lead for Chemical, Biological, Radiological, Nuclear (JPL CBRN) Integration
FY26 ABERDEEN PROVING
UPDATE SINCE FY25 APBI
UNCLASSIFIED/Approved for Public ReleaseFY26 APBI 49
• TOTAL ACTIONS BRIEFED: None
• RFPs RELEASED: 2
• ACTIONS AWARDED: 1
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or request for proposal and is not a commitment by the government to purchase products or services.”
CBRN INTEGRATED EARLY WARNING- AGILE SOFTWARE
DEVELOPMENT TEAMS
request for proposal and is not a commitment by the government to purchase products or services.”
FY26 APBI 3UNCLASSIFIED/Approved for Public Release
DESCRIPTION: Agile software development teams with the expertise to prototype, develop, and deliver mission-critical software. With the capability and capacity to produce functional, secure, scalable, and interoperable solutions.
Leveraging USG software development infrastructure, approved tools, and code repositories, enabling rapid development and in-process risk management. Allowing for the rapid adjustment of development objectives and priorities to address immediate and future operational needs.
CONTRACT TYPE and CONTRACT VEHICLE: OTA, BOTAA
ESTIMATED VALUE: $15-25M
CONTRACTING CONTACT: Army Contracting Command (ACC)-APG
DRAFT SOLICITATION RELEASE: RFI JAN2026
SOLICITATION #: TBD
ESTIMATED SOLICITATION RELEASE DATE: 2QFY26
PRIOR/CURRENT CONTRACT INFORMATION: N/A
“The content of this briefing is for informational purposes only and is subject to change. It does not represent a pre-solicitation synopsis, does not constitute an invitation for bid or
@CPECBRND
CONTACT
Paul Gietka Joint Project Lead for Chemical, Biological, Radiological and Nuclear Defense Integration
(410) 436-8476 paul.m.gietka.civ@army.mil https://www.linkedin.com/company/jpeocbrnd/ https://www.facebook.com/JPEOCBRND https://www.youtube.com/c/jpeocbrnd https://twitter.com/JPEOCBRND/ mailto:darryl.j.colvin.civ@army.mil
| FY26 ABERDEEN PROVING GROUND ADVANCED PLANNING BRIEFING TO INDUSTRY |
| CPE CBRND SPONSORED CONSORTIA |
| COUNTERING WEAPONS OF MASS DESTRUCTION (CWMD) OTHER TRANSACTION AGREEMENT (OTA) SCOPE |
| MEDICAL CBRN DEFENSE OTA SCOPE |
| KEY OTA FEATURES |
| TYPICAL SCHEDULE FOR ENHANCED WHITE PAPER |
| KEY PROGRAM ROLES & RESPONSIBILITIES |
| Slide Number 8 |
| Slide Number 9 |
| BROAD OTHER TRANSACTION AUTHORITY ANNOUNCEMENTS (BOTAA) |
| CONTACT |
| FY26 ABERDEEN PROVING GROUND ADVANCED PLANNING BRIEF TO INDUSTRY |
| FY26 APBI |
UPDATE SINCE FY25 APBI
| WEARABLE ALL HAZARD REMOTE MONITORING PROGRAM – INCREMENT 2 (WARP 2) | |
| FAR FORWARD BIOLOGICAL SEQUENCING (FFBS) – INCREMENT 3 | |
| FORWARD AREA MOBILITY SPRAY-SYSTEM (FAMS-S) AIRCRAFT INTERIOR DECONTAMINATION (AID) | |
| FY26 ABERDEEN PROVING GROUND ADVANCED PLANNING BRIEFING TO INDUSTRY | |
| DATA & TECHNOLOGY INTEGRATION FOR READINESS (DTIR) | JPL EB |
| RAPID ACCESS TO PRODUCTS IN DEVELOPMENT (RAPID) | |
| CBRN ADVANCE DEFENSE ENABLING NETWORK AND CLINICAL CAPABILITY | (CADENCC) |
| PROACTIVE ADVANCED COUNTERMEASURE EVALUATION (PACE) | |
| GENERATIVE UNCONSTRAINED INTELLIGENT DRUG ENGINEERING | (GUIDE) |
| ADVANCING TECHNOLOGY PLATFORMS (ATP) |
JPL EB
| NEW MODALITIES FOR PROPHYLACTIC MEDICAL COUNTERMEASURES |
| MEDICAL COUNTERMEASURE MANUFACTURING OPTIMIZATION |
| NON-HUMAN PRIMATE (NHP) PRIORITY ACCESS |
| NEW ALTERNATIVE METHODS FOR THE EVALUATION OF MEDICAL COUNTERMEASURES |
| CONTACT |
| FY26 ABERDEEN PROVING GROUND ADVANCED PLANNING BRIEFING TO INDUSTRY |
| OVERVIEW OF PARTNERING VEHICLES |
| PROFESSIONAL SUPPORT SERVICES (OASIS+) |
| JE-CLASS II |
| Slide Number 33 |
| CBRN COMMERCIAL ITEM IDIQ |
| ARMY OPEN SOLICITATION (AOS) |
| MEDICAL COUNTERMEASURES BAA |
| CWMD BOTAA |
| DOING FAR-BASED BUSINESS WITH THE GOVERNMENT |
| CONTACT |
| FY26 ABERDEEN PROVING GROUND ADVANCED PLANNING BRIEFING TO INDUSTRY |
| FY26 APBI |
UPDATE SINCE FY25 APBI
| BEACON |
| PROTECS |
| HOST DIRECTED THERAPEUTICS (HD TX) |
| PROPHYLAXIS IN ADVANCED DEVELOPMENT (PAD) |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .